RO85245B1 - Process for preparing oab blood test serums - Google Patents

Process for preparing oab blood test serums

Info

Publication number
RO85245B1
RO85245B1 RO109251A RO10925182A RO85245B1 RO 85245 B1 RO85245 B1 RO 85245B1 RO 109251 A RO109251 A RO 109251A RO 10925182 A RO10925182 A RO 10925182A RO 85245 B1 RO85245 B1 RO 85245B1
Authority
RO
Romania
Prior art keywords
oab
preparing
blood test
test serums
serums
Prior art date
Application number
RO109251A
Other languages
Romanian (ro)
Other versions
RO85245A2 (en
Inventor
Maria Danielescu
Lauretia Onfriciuc
Maria Radulian
Silvia Elvira Elena Sirian
Maria Baclagian
Ecaterina Iacob
Ana Crohinov
Vlad Apateanu
Original Assignee
Centrul De Hematologie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centrul De Hematologie filed Critical Centrul De Hematologie
Priority to RO109251A priority Critical patent/RO85245B1/en
Publication of RO85245A2 publication Critical patent/RO85245A2/en
Publication of RO85245B1 publication Critical patent/RO85245B1/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Procedeu de obtinere a serurilor hemostat OAB, ce consta în aceea ca, plasma obtinuta prin plasmaforeza de la donatorii de sînge de grup OAB, ce prezinta titru mai mic sau egal 1/256, aviditate mai mare de 45 secunde si specificitate se defibrineazacu trombina, se centrifugheaza la 4 degree C, timp de 30 min, se concentreaza printr-o membrana de dializa dupa care se filtreaza în conditii sterile. OAB hemostat serum obtained by plasma derived plasma from OAB group blood donors, which has a titer of less than or equal to 1/256, avidity greater than 45 seconds, and specificity is defibrinated with thrombin, is centrifuged at 4 ° C for 30 minutes, concentrated through a dialysis membrane and then filtered under sterile conditions.

RO109251A 1982-12-08 1982-12-08 Process for preparing oab blood test serums RO85245B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RO109251A RO85245B1 (en) 1982-12-08 1982-12-08 Process for preparing oab blood test serums

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RO109251A RO85245B1 (en) 1982-12-08 1982-12-08 Process for preparing oab blood test serums

Publications (2)

Publication Number Publication Date
RO85245A2 RO85245A2 (en) 1984-09-29
RO85245B1 true RO85245B1 (en) 1984-10-30

Family

ID=20112331

Family Applications (1)

Application Number Title Priority Date Filing Date
RO109251A RO85245B1 (en) 1982-12-08 1982-12-08 Process for preparing oab blood test serums

Country Status (1)

Country Link
RO (1) RO85245B1 (en)

Also Published As

Publication number Publication date
RO85245A2 (en) 1984-09-29

Similar Documents

Publication Publication Date Title
Pahwa et al. Stimulatory and inhibitory influences of human immunodeficiency virus on normal B lymphocytes.
Andersson et al. K562—a human erythroleukemic cell line
McElrath et al. Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections.
Perez et al. An HIV-1-infected T cell clone defective in IL-2 production and Ca2+ mobilization after CD3 stimulation
Matsushita et al. Human monoclonal antibody directed against an envelope glycoprotein of human T-cell leukemia virus type I.
ATE107353T1 (en) PLATELET LYSATE, PROCESS FOR ITS PREPARATION AND CELL CULTURE MEDIUM CONTAINING SUCH LYSATE.
Mathews et al. Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies
Ahmed et al. Demonstration of a blocking factor in the plasma and spinal fluid of patients with subacute sclerosing panencephalitis: I. Partial characterization
OA08652A (en) Compositions, vaccine and monoclonal antibodies useful for the treatment of conditions caused by the HIV virus and methods for producing these antibodies and for diagnosing the presence of this virus.
Blumberg et al. Antibody-dependent cell-mediated cytotoxicity against cells infected with the human immunodeficiency virus
DK154091B (en) PROCEDURE FOR PREPARING A MONOCLONAL ANTIBODY AND PROCEDURES FOR DIAGNOSIS THEREOF AND DIAGNOSTIC PREPARATION CONTAINING ANTIBODY
Shugars et al. Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type 1
Dutta-Roy et al. Prostacyclin stimulation of the activation of blood coagulation factor X by platelets
Martínez-Maza et al. Frequencies of the separate human B cell subsets activatable to Ig secretion by Epstein-Barr virus and pokeweed mitogen.
Foster et al. Specific suppression of human CD4 surface expression by Nef from the pathogenic simian immunodeficiency virus SIVmac239open
US5286852A (en) Antibodies specific towards HIV-1 gp 48
RO85245B1 (en) Process for preparing oab blood test serums
SE8701628D0 (en) MEANS OF ANALYSIS MM
Nour-Eldin et al. The blood clotting factors in human saliva
ES546974A0 (en) A PROCEDURE FOR ELIMINATION OF THE VIRUS LAV.
Biddison et al. Characterization and specificity of murine anti-tumor cytotoxic effector cells within an ascitic tumor
Pantazis et al. Synthesis of the third component of complement (C3) by lectin-activated and HTLV-infected human T-cells
Schneweis et al. Comparison of different methods for detecting human immune deficiency virus in human immunodeficiency virus‐seropositive hemophiliacs
Hardwicke et al. Human α1-glycoproteins Separation from pathological urine and examination by immunological and electrophoretic methods
Praz et al. Alternative pathway of complement activation by human lymphoblastoid B and T cell lines.